Bone Biologics, a developer of advanced orthobiologic products, has filed a U.S. patent application for its NELL-1 protein technology. This novel approach aims to improve the success rates of spinal fusion surgery and address significant unmet needs in the multi-billion-dollar bone graft market.
Deutsch
English
Español
Français
Italiano
Nederlands
Polski
Português
Русский
Türkçe
Svenska
Chinese
Magyar